PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics (NASDAQ: PTCT) has announced its participation in three major healthcare investor conferences in November and December 2024. The company will present overviews at the UBS Global Healthcare Conference on November 13, the Jefferies London Healthcare Conference on November 19, and Citi's 2024 Global Healthcare Conference on December 3.
All presentations will be available via webcast on PTC's investor relations website and will remain accessible for 30 days after each event. Viewers are advised to connect several minutes before the scheduled start times to ensure proper connection.
PTC Therapeutics (NASDAQ: PTCT) ha annunciato la sua partecipazione a tre importanti conferenze per investitori nel settore sanitario che si terranno a novembre e dicembre 2024. L'azienda presenterà panoramiche alla UBS Global Healthcare Conference il 13 novembre, alla Jefferies London Healthcare Conference il 19 novembre e alla Conferenza Globale sulla Salute di Citi del 2024 il 3 dicembre.
Tutte le presentazioni saranno disponibili in webcast sul sito web delle relazioni con gli investitori di PTC e rimarranno accessibili per 30 giorni dopo ciascun evento. Si consiglia agli spettatori di connettersi alcuni minuti prima degli orari di inizio previsti per garantire una connessione adeguata.
PTC Therapeutics (NASDAQ: PTCT) ha anunciado su participación en tres importantes conferencias de inversores en el sector de la salud que se celebrarán en noviembre y diciembre de 2024. La compañía presentará resúmenes en la UBS Global Healthcare Conference el 13 de noviembre, en la Jefferies London Healthcare Conference el 19 de noviembre y en la Conferencia Global de Salud de Citi 2024 el 3 de diciembre.
Todas las presentaciones estarán disponibles a través de un webcast en el sitio web de relaciones con inversores de PTC y seguirán accesibles durante 30 días después de cada evento. Se aconseja a los espectadores que se conecten varios minutos antes de los horarios programados para asegurar una conexión adecuada.
PTC Therapeutics (NASDAQ: PTCT)는 2024년 11월과 12월에 열리는 세 가지 주요 헬스케어 투자자 컨퍼런스에 참가한다고 발표했습니다. 회사는 11월 13일 UBS 글로벌 헬스케어 컨퍼런스, 11월 19일 제프리스 런던 헬스케어 컨퍼런스, 12월 3일 씨티의 2024 글로벌 헬스케어 컨퍼런스에서 개요를 발표할 것입니다.
모든 발표는 PTC의 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며 각 이벤트 후 30일 동안 접근 가능합니다. 시청자들은 예정된 시작 시간 몇 분 전에 연결하여 적절한 연결을 보장하는 것이 좋습니다.
PTC Therapeutics (NASDAQ: PTCT) a annoncé sa participation à trois grandes conférences d'investisseurs dans le secteur de la santé qui se tiendront en novembre et décembre 2024. La société présentera des aperçus lors de la Conférence mondiale sur la santé d'UBS le 13 novembre, de la Conférence sur la santé de Jefferies à Londres le 19 novembre et de la Conférence mondiale sur la santé de Citi 2024 le 3 décembre.
Toutes les présentations seront disponibles via webdiffusion sur le site des relations avec les investisseurs de PTC et resteront accessibles pendant 30 jours après chaque événement. Il est conseillé aux spectateurs de se connecter quelques minutes avant les horaires de début prévus pour garantir une connexion adéquate.
PTC Therapeutics (NASDAQ: PTCT) hat seine Teilnahme an drei wichtigen Investorenkonferenzen im Gesundheitswesen im November und Dezember 2024 angekündigt. Das Unternehmen wird Überblickspräsentationen auf der UBS Global Healthcare Conference am 13. November, der Jefferies London Healthcare Conference am 19. November und der Citi's 2024 Global Healthcare Conference am 3. Dezember halten.
Alle Präsentationen werden über Webcast auf der Investor-Relations-Website von PTC verfügbar sein und sind 30 Tage lang nach jeder Veranstaltung zugänglich. Den Zuschauern wird geraten, sich einige Minuten vor den geplanten Startzeiten zu verbinden, um eine ordnungsgemäße Verbindung sicherzustellen.
- None.
- None.
UBS Global Healthcare Conference
Wednesday, Nov. 13 at 2:45 p.m. PST / 5:45 p.m. EST
Jefferies London Healthcare Conference
Tuesday, Nov. 19 at 11:30 a.m. GMT / 6:30 a.m. EST
Citi's 2024 Global Healthcare Conference
Tuesday, Dec. 3 at 2:30 p.m. EST
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on X (formerly Twitter), and on LinkedIn.
For More Information:
Investors:
Investor Relations
+1 (908) 912-9848
ir@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302295727.html
SOURCE PTC Therapeutics, Inc.
FAQ
What investor conferences will PTC Therapeutics (PTCT) attend in November-December 2024?
How long will PTC Therapeutics (PTCT) conference webcasts be available for viewing?
Where can investors watch PTC Therapeutics (PTCT) conference presentations?